trending Market Intelligence /marketintelligence/en/news-insights/trending/ayn-bbkvjh8xhxx6zvtlvq2 content esgSubNav
In This List

Linden Capital Partners acquires clinical research business Evolution Research

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Linden Capital Partners acquires clinical research business Evolution Research

Healthcare-focused private equity firm Linden Capital Partners completed the acquisition of independent clinical research site business Evolution Research Group LLC.

The deal, financial terms of which were not disclosed, builds on Linden's pharmaceutical services sub-sector strategy.

Watchung, N.J.-based Evolution Research, which provides medical and scientific clinical research site services in the neurosciences area, has completed over 5,000 clinical trials in phases 1 to 4.

Senior debt financing for the deal was provided by Golub Capital.

Kirkland & Ellis LLP served as legal adviser to Chicago-based Linden. Harris Williams & Co., Edgemont Capital Partners, and Ice Miller LLP served as financial and legal advisers to Evolution Research.